Filing Details
- Accession Number:
- 0001209191-18-033088
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-24 17:28:17
- Reporting Period:
- 2018-03-08
- Accepted Time:
- 2018-05-24 17:28:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1711279 | Krystal Biotech Inc. | KRYS | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1339375 | A Antony Riley | 2100 Wharton Street Suite 701 Pittsburgh PA 15203 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-05-22 | 2,800 | $10.75 | 2,800 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2018-03-08 | 25,000 | $0.00 | 25,000 | $9.85 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
25,000 | 2028-03-08 | No | 4 | A | Direct |
Footnotes
- The options were awarded on March 8, 2018 and vest ratably over a four-year period.